GEN Exclusives

More »

GEN News Highlights

More »
Oct 20, 2009

DiscoveRx Technologies to Support Evotec’s HTS Services

  • Evotec and DiscoveRx inked a co-marketing deal for the screening of GPCR’s and other targets. Evotec will have access to DiscoveRx’ PathHunter™ and cAMPHunter™ cell lines as well as EFC chemiluminescent detection technology for use during hit identification and optimization projects performed for Evotec customers.
     
    DiscoveRx’ EFC-related technologies offer assay solutions for every major class of drug target including GPCRs, kinases, proteases, nuclear hormone receptors, and secreted proteins, the company points out. “For our customers this agreement means that DiscoveRx’ innovative assay portfolio of more than 300 cell-based GPCR assays can be accessed in conjunction with the first-class high-throughput screening set-up at Evotec,” notes Evotec’s evp, business development, Mark Ashton
     


Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Stopping Research Fraud

What is the best approach to curbing scientific misconduct and outright fraud?